[HTML][HTML] Sex-specific differences in glioblastoma

A Carrano, JJ Juarez, D Incontri, A Ibarra, HG Cazares - Cells, 2021 - mdpi.com
Sex differences have been well identified in many brain tumors. Even though glioblastoma
(GBM) is the most common primary malignant brain tumor in adults and has the worst …

[HTML][HTML] Modified criteria for radiographic response assessment in glioblastoma clinical trials

BM Ellingson, PY Wen, TF Cloughesy - Neurotherapeutics, 2017 - Elsevier
Radiographic endpoints including response and progression are important for the
evaluation of new glioblastoma therapies. The current RANO criteria was developed to …

Neural stem cells as potential glioblastoma cells of origin

A Loras, LG Gonzalez-Bonet, JL Gutierrez-Arroyo… - Life, 2023 - mdpi.com
Glioblastoma multiforme (GBM) is the most malignant brain tumor in adults and it remains
incurable. These tumors are very heterogeneous, resistant to cytotoxic therapies, and they …

Glioma infiltration and extracellular matrix: key players and modulators

VP Ferrer, V Moura Neto, R Mentlein - Glia, 2018 - Wiley Online Library
An outstanding characteristic of gliomas is their infiltration into brain parenchyma, a property
that impairs complete surgical resection; consequently, these tumors might recur, resulting in …

[HTML][HTML] The use of photodynamic therapy in the treatment of brain tumors—A review of the literature

D Bartusik-Aebisher, A Żołyniak, E Barnaś… - Molecules, 2022 - mdpi.com
The treatment of neoplastic disease of the brain is still a challenge for modern medicine.
Therefore, advanced methodologies are needed that can rationally and successfully …

Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study

P Zhu, XL Du, G Lu, JJ Zhu - Oncotarget, 2017 - pmc.ncbi.nlm.nih.gov
Few population-based analyses have investigated survival change in glioblastoma
multiforme (GBM) patients treated with concomitant radiotherapy-temozolomide (RT-TMZ) …

Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009

D Gramatzki, S Dehler, EJ Rushing, K Zaugg, S Hofer… - Cancer, 2016 - Wiley Online Library
BACKGROUND A population‐based analysis of patients with glioma diagnosed between
1980 and 1994 in the Canton of Zurich in Switzerland confirmed the overall poor prognosis …

Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

BM Ellingson, LE Abrey, SJ Nelson… - Neuro …, 2018 - academic.oup.com
Background In the current study, we pooled imaging data in newly diagnosed glioblastoma
(GBM) patients from international multicenter clinical trials, single institution databases, and …

The association between race and survival in glioblastoma patients in the US: a retrospective cohort study

A Bohn, A Braley, P Rodriguez de la Vega… - PloS one, 2018 - journals.plos.org
Background Glioblastoma is the most common primary brain cancer in adults with an
incidence of 3.4 per 100,000, making up about 15% of all brain tumors. Inconsistent results …

Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression

R Wei, J Zhou, B Bui, X Liu - BMC cancer, 2024 - Springer
The intricate interplay between cancer cells and their surrounding microenvironment has
emerged as a critical factor driving the aggressive progression of various malignancies …